Certified Nutraceuticals' KollaJell™ Granted Patent in China

First-of-its-kind jellyfish collagen contains all essential and nonessential amino acids for brain health and cognitive function

Certified Nutraceuticals Inc., a manufacturer of natural, scienced-based ingredients for foods, beverages and supplements, announced on December 15, 2021 that the China National Intellectual Property Administration has issued Patent No. ZL 2017 1 1177638.2 for the company’s Type I, Type II, Type V hydrolyzed jellyfish collagen and its application. Marketed under the brand KollaJell™, this unique product is the only collagen containing all 20 essential and nonessential amino acids needed for healthy brain and cognitive function.

KollaJell is rich in amino acids – glutamate, glycine, tryptophan and tyrosine – that form neurotransmitters that enable thinking, learning and memory. These amino acids are also precursors for serotonin, GABA, dopamine and norepinephrine that help regulate mood, energy and sleep.

KollaJell also contains calcium-binding proteins, neuroprotective antioxidants and high amounts of vital macronutrients for brain health not found in any other type of collagen. These include sodium, potassium, phosphorus, chloride, copper, calcium, magnesium, manganese, sulfur, zinc, iron and silicon.

Rhizostoma pulmo

KollaJell is sourced from edible wild-caught cannonball jellyfish (Stomolophus meleagris) and barrel jellyfish (Rhizostoma pulmo). KollaJell is protected by U.S. Patent Number 10,287,339 B2.

“KollaJell is a ‘super food’ for the brain,” said Abdul Alkayali, Certified Nutraceuticals Senior Vice President, Sales and Marketing. “It is an abundant source of amino acids that enable neurons to communicate with each other. In addition, collagen is a major component of the extracellular matrix, which provides structure for the brain and regulates several fundamental neural processes.”

KollaJell is marketed worldwide through Certified Nutraceuticals and its marketing partners.

Source: https://www.einnews.com/

Editor: IPRdaily-Rene